Hayek Kallen Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.29M | Sell |
94,912
-1,227
| -1% | -$32.1K | 0.69% | 38 |
|
|
2026
Q1 | $2.7M | Buy |
+96,139
| New | +$2.56M | 0.88% | 36 |
|
|
2025
Q4 | – | Sell |
-105,093
| Closed | -$2.68M | – | 154 |
|
|
2025
Q3 | $2.68M | Sell |
105,093
-1,392
| -1% | -$34.4K | 0.85% | 32 |
|
|
2025
Q2 | $2.58M | Sell |
106,485
-85
| -0.1% | -$1.98K | 0.88% | 32 |
|
|
2025
Q1 | $2.7M | Buy |
106,570
+3,588
| +3% | +$93.9K | 0.99% | 31 |
|
|
2024
Q4 | $2.73M | Sell |
102,982
-3,598
| -3% | -$97.6K | 0.99% | 30 |
|
|
2024
Q3 | $3.08M | Sell |
106,580
-334
| -0.3% | -$9.74K | 1.09% | 28 |
|
|
2024
Q2 | $2.99M | Sell |
106,914
-506
| -0.5% | -$13.9K | 1.12% | 29 |
|
|
2024
Q1 | $2.98M | Buy |
107,420
+3,873
| +4% | +$107K | 1.14% | 29 |
|
|
2023
Q4 | $2.98M | Buy |
103,547
+1,355
| +1% | +$41K | 1.24% | 28 |
|
|
2023
Q3 | $3.39M | Buy |
102,192
+665
| +0.7% | +$23.5K | 1.52% | 24 |
|
|
2023
Q2 | $3.72M | Buy |
101,527
+2,813
| +3% | +$109K | 1.58% | 21 |
|
|
2023
Q1 | $4.03M | Sell |
98,714
-2,298
| -2% | -$99.3K | 1.82% | 18 |
|
|
2022
Q4 | $5.18M | Sell |
101,012
-2,360
| -2% | -$113K | 2.39% | 12 |
|
|
2022
Q3 | $4.52M | Sell |
103,372
-8
| -0% | -$389 | 2.12% | 12 |
|
|
2022
Q2 | $5.42M | Sell |
103,380
-170
| -0.2% | -$8.66K | 2.36% | 11 |
|
|
2022
Q1 | $5.36M | Sell |
103,550
-122
| -0.1% | -$6.33K | 1.99% | 15 |
|
|
2021
Q4 | $6.12M | Sell |
103,672
-679
| -0.7% | -$33.6K | 2.18% | 12 |
|
|
2021
Q3 | $4.49M | Sell |
104,351
-562
| -0.5% | -$24.9K | 2.05% | 16 |
|
|
2021
Q2 | $4.11M | Buy |
104,913
+392
| +0.4% | +$15.2K | 1.73% | 21 |
|
|
2021
Q1 | $3.79M | Buy |
104,521
+364
| +0.3% | +$12.9K | 1.71% | 22 |
|
|
2020
Q4 | $3.83M | Sell |
104,157
-5,166
| -5% | -$189K | 1.85% | 20 |
|
|
2020
Q3 | $3.81M | Buy |
109,323
+24
| +0% | +$841 | 2.13% | 13 |
|
|
2020
Q2 | $3.39M | Buy |
109,299
+2,792
| +3% | +$94.9K | 1.92% | 18 |
|
|
2020
Q1 | $3.3M | Buy |
106,507
+229
| +0.2% | +$7.8K | 2.21% | 16 |
|
|
2019
Q4 | $3.95M | Buy |
106,278
+2,525
| +2% | +$89.9K | 2.28% | 15 |
|
|
2019
Q3 | $3.54M | Buy |
103,753
+1,243
| +1% | +$45.2K | 2.21% | 18 |
|
|
2019
Q2 | $4.21M | Buy |
102,510
+325
| +0.3% | +$12.9K | 2.67% | 11 |
|
|
2019
Q1 | $4.12M | Buy |
102,185
+840
| +0.8% | +$33.6K | 2.67% | 13 |
|
|
2018
Q4 | $4.2M | Sell |
101,345
-447
| -0.4% | -$18.6K | 3.01% | 10 |
|
|
2018
Q3 | $4.26M | Sell |
101,792
-492
| -0.5% | -$18.9K | 2.73% | 12 |
|
|
2018
Q2 | $3.52M | Sell |
102,284
-1,883
| -2% | -$64.3K | 2.43% | 14 |
|
|
2018
Q1 | $3.51M | Sell |
104,167
-2,481
| -2% | -$85.3K | 2.43% | 15 |
|
|
2017
Q4 | $3.66M | Sell |
106,648
-2,112
| -2% | -$72K | 2.4% | 16 |
|
|
2017
Q3 | $3.68M | Sell |
108,760
-288
| -0.3% | -$9.26K | 2.52% | 14 |
|
|
2017
Q2 | $3.48M | Buy |
109,048
+6,993
| +7% | +$221K | 2.35% | 18 |
|
|
2017
Q1 | $3.31M | Buy |
102,055
+5,348
| +6% | +$169K | 2.3% | 18 |
|
|
2016
Q4 | $2.98M | Buy |
96,707
+2,145
| +2% | +$65.5K | 2.17% | 22 |
|
|
2016
Q3 | $3.04M | Buy |
94,562
+3,360
| +4% | +$112K | 2.17% | 24 |
|
|
2016
Q2 | $3.05M | Buy |
91,202
+1,537
| +2% | +$49.1K | 2.19% | 23 |
|
|
2016
Q1 | $2.52M | Buy |
89,665
+3,822
| +4% | +$109K | 1.87% | 27 |
|
|
2015
Q4 | $2.63M | Sell |
85,843
-387
| -0.4% | -$12.2K | 2.01% | 25 |
|
|
2015
Q3 | $2.57M | Sell |
86,230
-1,622
| -2% | -$52K | 2% | 26 |
|
|
2015
Q2 | $2.79M | Buy |
87,852
+7,386
| +9% | +$241K | 2.09% | 23 |
|
|
2015
Q1 | $2.66M | Buy |
80,466
+2,425
| +3% | +$77.1K | 1.96% | 25 |
|
|
2014
Q4 | $2.31M | Buy |
78,041
+3,741
| +5% | +$107K | 1.7% | 27 |
|
|
2014
Q3 | $2.08M | Buy |
74,300
+18,899
| +34% | +$530K | 1.59% | 27 |
|
|
2014
Q2 | $1.56M | Buy |
55,401
+10,148
| +22% | +$289K | 1.18% | 30 |
|
|
2014
Q1 | $1.38M | Buy |
45,253
+3,500
| +8% | +$104K | 1.1% | 31 |
|
|
2013
Q4 | $1.21M | Buy |
41,753
+1,442
| +4% | +$42K | 0.94% | 33 |
|
|
2013
Q3 | $1.1M | Buy |
40,311
+3,125
| +8% | +$85K | 0.91% | 34 |
|
|
2013
Q2 | $988K | Buy |
+37,186
| New | +$1.03M | 0.84% | 36 |
|
Other funds holding PFE
Hayek Kallen Investment Management's PFE Position: Q2 2026 in Review
Hayek Kallen Investment Management reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $32.1K and leaving 94,912 shares worth $2.29M. The position accounts for 0.69% of the portfolio, ranked #38.
Hayek Kallen Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.12M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hayek Kallen Investment Management held 94,912 shares of Pfizer worth $2.29M as of Q2 2026.
- Hayek Kallen Investment Management sold 1,227 Pfizer shares in Q2 2026, an estimated $32.1K.
- Pfizer made up 0.69% of Hayek Kallen Investment Management's portfolio in Q2 2026, its #38 holding.
- Hayek Kallen Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Hayek Kallen Investment Management's Pfizer position peaked at $6.12M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hayek Kallen Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.